OnKure Therapeutics, Inc. - OKUR
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 03, 2026 | Chief Medical Officer | A | A | 110,000.0 | 0.0 | 0.0 | 110,000.0 | View | |
| Apr 03, 2026 | Chief Scientific Officer | A | A | 110,000.0 | 0.0 | 0.0 | 110,000.0 | View | |
| Apr 03, 2026 | Chief Financial Officer | A | A | 110,000.0 | 0.0 | 0.0 | 110,000.0 | View | |
| Apr 03, 2026 | President and CEO | A | A | 330,000.0 | 0.0 | 0.0 | 330,000.0 | View | |
| Apr 01, 2026 | — | A | A | 15,300.0 | 0.0 | 0.0 | 15,300.0 | View | |
| Mar 24, 2026 | Chief Financial Officer | S | D | 301.0 | 4.1565 | 1,251.11 | 16,000.0 | View | |
| Mar 24, 2026 | President and CEO | S | D | 86.0 | 4.1565 | 357.46 | 7,333.0 | View | |
| Jan 02, 2026 | — | A | A | 5,258.0 | 0.0 | 0.0 | 20,583.0 | View | |
| Jan 02, 2026 | — | A | A | 3,911.0 | 0.0 | 0.0 | 15,310.0 | View | |
| Dec 23, 2025 | President and CEO | S | D | 87.0 | 2.9677 | 258.19 | 7,419.0 | View | |
| Dec 23, 2025 | Chief Financial Officer | S | D | 302.0 | 2.9677 | 896.25 | 16,301.0 | View |